H.R. 9482

H.R. 9482: To prohibit data brokers from selling and transferring certain sensitive data.

Introduced Mary Scanlon (D) HOUSE_BILL — 119th Congress
Plain English Summary

H.R. 9482 is a proposed law aimed at preventing data brokers from selling or transferring sensitive personal information without consent. This includes data that could identify individuals and is considered private, such as health records, financial information, and other personal identifiers.

Positive Media Summary

Supporters of H.R. 9482 argue that the bill is a necessary step towards protecting consumer privacy in an increasingly digital world. Media outlets have highlighted the potential for this legislation to empower individuals by giving them more control over their personal data and reducing the risk of identity theft and misuse of sensitive information.

Negative Media Summary

Critics of H.R. 9482 express concerns that the bill may impose excessive regulations on data brokers, potentially stifling innovation and limiting the availability of valuable data for businesses. Some media reports have raised alarms about the potential economic impact, suggesting that such restrictions could hinder legitimate data-driven services and analytics.

Conflict of Interest Analysis Deep Analysis
2/10
Risk Level
Low
Total Donations
$0
PAC Percentage
0%
Policy Area
Commerce

The analysis of H.R. 9482, which aims to prohibit data brokers from selling and transferring certain sensitive data, reveals no direct industry overlaps between the bill's subject matter and the sponsor Mary Scanlon's top donor industries. While there is lobbying activity in related areas, such as Vertex Pharmaceuticals and Verizon Communications, the amounts disclosed do not indicate a direct financial influence on the bill's content. The total disclosed lobbying amounts are $60,000 from Vertex Pharmaceuticals and $20,000 from Smart Approaches to Marijuana, but these do not correlate with the data privacy focus of the legislation. Therefore, the risk of conflict of interest appears minimal, as the sponsor's financial backers do not have a vested interest in opposing or supporting the bill's objectives.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
VERTEX PHARMACEUTICALS INCORPORATED MARSHALL & POPP, LLC $60,000
SUN PHARMACEUTICAL INDUSTRIES, INC. MARSHALL & POPP, LLC $60,000
SANOFI U.S. SERVICES, INC. MARSHALL & POPP, LLC $60,000
WAYFINDER GROUP (OBO RESEARCH CORPORATION OF THE UNIVERSITY OF HAWAII) RED MAPLE CONSULTING, LLC $40,000
ECKERD CONNECTS KOUNTOUPES DENHAM CARR & REID, LLC $30,000
SMART APPROACHES TO MARIJUANA OFF HILL STRATEGIES L.L.C. $20,000
FEDERATION OF ELECTRIC POWER COS OF JAPAN GEORGE H. DENISON $10,000
MAYO CLINIC MCDERMOTT WILL & SCHULTE LLP undisclosed
VERIZON COMMUNICATIONS, INC. MARSHALL & POPP, LLC undisclosed
THE BIG TEN CONFERENCE, INC. MARSHALL & POPP, LLC undisclosed
THE BIG 12 CONFERENCE, INC. MARSHALL & POPP, LLC undisclosed
SOUTHEASTERN CONFERENCE MARSHALL & POPP, LLC undisclosed
PAC-12 CONFERENCE MARSHALL & POPP, LLC undisclosed
ATLANTIC COAST CONFERENCE MARSHALL & POPP, LLC undisclosed
SAPPHIRE DIGITAL MARSHALL & POPP, LLC undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding Mary Scanlon, ranked by total contributions.

Health Professionals $240,000,000
Individuals: $240,000,000 PACs: $0
Retired $75,000,000
Individuals: $75,000,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us